- Home | Abiomed. com
Abiomed® is committed to leading in technology and innovation, and improving patient outcomes by developing smaller, smarter and more connected technology
- Explore Impella® Technology - Abiomed
Learn more about how the FDA-approved Impella, the world's smallest heart pump, is safe, effective and supports your heart during a procedure Hear the stories of patients and explore the latest innovations in Impella technology
- Careers at Abiomed | Abiomed. com
Abiomed is proud to be part of the Johnson Johnson MedTech family For more details, visit J J Careers
- Abiomed Turns Into Johnson Johnson MedTech | Abiomed. com
In 2022, a new chapter in our history began when the world's largest medical technology company, Johnson Johnson (J J), acquired Abiomed as part of its portfolio
- Our Story | Abiomed. com
Abiomed was founded in 1981 for the purpose of developing the world's first artificial heart This interactive timeline shows how Abiomed’s mission evolved to focus on native heart recovery
- Explore Abiomed® Products and Clinical Services
Abiomed is committed to leading in technology and innovation, and improving patient outcomes by developing smaller, smarter and more connected technology Explore Future Innovations
- Abiomed® - Leading in Heart and Lung Recovery
Abiomed is a leading provider of groundbreaking medical technology that provides circulatory and oxygenation support
- Johnson Johnson Completes Acquisition of Abiomed
Johnson Johnson (NYSE: JNJ), the world’s largest, most diversified healthcare products company, today announced it has completed its acquisition of Abiomed, Inc Abiomed is now part of Johnson Johnson and will operate as a standalone business within Johnson Johnson’s MedTech segment
|